1. Consensus Document. (1990): Hawk’s Cay Meeting on Therapeutic Drug Monitoring of cyclosporine. Transplant Proc., 22, 1357–1361.
2. Maurer G., Loosli H.R., Schreier E., Keller B. (1984): Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metab. Dispos., 12, 120–127.
3. Kronbach T., Fischer V., Meyer U.A. (1988): Cyclosporine metabolism in human liver: identification of a cytochrome P450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin. Pharmacol. Ther., 43, 630–635.
4. Combalbert J., Fabre I., Fabre G. et al. (1989): Metabolism of cyclosporine A. IV. Purification and identification of rifampicin-inducible human liver cytochrome P-450 (cyclosporine A oxidase) as a product of P-450 IIIA gene subfamily. Drug Metab. Dispos., 17, 197–207.
5. Waxman D.J., Dannan G.A., Guengerich F.P. (1985): Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isozymes. Biochemistry, 24, 4409–4417.